Anticorps Monoclonal anti-TGFBI / BIGH3
TGFBI / BIGH3 Monoclonal Antibody for Single Cell (Intra)
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain
Applications
Single Cell (Intra)
Conjugaison
5CFLX Fluorescent Dye
CloneNo.
3E11D11
N° de cat : G60007-1-5C
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en Single Cell (Intra) | 10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing product. |
Dilution recommandée
| Application | Dilution |
|---|---|
| SINGLE CELL (INTRA) | SINGLE CELL (INTRA) : <0.5ug/test |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
G60007-1-5C cible TGFBI / BIGH3 dans les applications de Single Cell (Intra) et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Mouse / IgG2a |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | TGFBI / BIGH3 Protéine recombinante Ag0241 |
| Nom complet | transforming growth factor, beta-induced, 68kDa |
| Masse moléculaire calculée | 683 aa, 75 kDa |
| Numéro d’acquisition GenBank | BC000097 |
| Symbole du gène | TGFBI |
| Identification du gène (NCBI) | 7045 |
| Conjugaison | 5CFLX Fluorescent Dye |
| Forme | Liquide |
| Méthode de purification | |
| Tampon de stockage | PBS with 1mM EDTA and 0.09% sodium azide |
| Conditions de stockage | 2-8°C Stable for one year after shipment. 20ul contiennent 0,1% de BSA. |
Informations générales
TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).

